SciVision Biotech Inc., headquartered in Taiwan (TW), is a leading player in the biotechnology industry, specialising in innovative solutions for the healthcare sector. Founded in 2005, the company has made significant strides in developing advanced diagnostic tools and therapeutic products, positioning itself as a trusted name in the field. With a focus on molecular diagnostics and biopharmaceuticals, SciVision Biotech offers unique products that leverage cutting-edge technology to enhance patient care. Their commitment to quality and innovation has earned them recognition in both domestic and international markets, solidifying their reputation as a pioneer in biotechnology. As they continue to expand their operational reach, SciVision Biotech remains dedicated to advancing healthcare through scientific excellence and innovative solutions.
How does SciVision Biotech Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SciVision Biotech Inc.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SciVision Biotech Inc., headquartered in Taiwan (TW), currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. The company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As a result, there is no information on their scope of emissions (Scope 1, 2, or 3) or any significant achievements in reducing carbon emissions. Without specific data or commitments, it is unclear how SciVision Biotech Inc. is addressing climate change or contributing to sustainability efforts within the biotechnology sector.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SciVision Biotech Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
